Newsletter

Business urges review of medical law “Please continue to receive non-face-to-face treatment”


Reporter Lim Dong-wook of Money Today | 2023.05.04 10:00


(Seoul=News 1) Reporter Lim Se-young = On the 17th, at the Boas Ear Biology Hospital in Jung-gu, Seoul, Director Oh Jae-guk calls a patient who was confirmed to have Corona 19 yesterday and sees a faceless – facial treatment. Since the 10th, the government has carried out wire monitoring mainly for the ‘intensive control group’ among confirmed corona19 patients, and the general control group has entered a new home treatment system where they receive non-face-to-face treatment in local hospitals and clinics. 2022.2.17/News 1

“Please allow us to continue receiving the current non-face-to-face treatment.”

The business world is demanding that the medical law be amended as soon as possible so that the current non-face-to-face treatment can continue. It is a request to establish non-face-to-face treatment between medical personnel and patients by revising the law, and open a way through a pilot project until the system is improved if it is difficult to revise the law immediately .

On the 4th, there are six economic organizations, including the Korea Chamber of Commerce and Industry, the Korea Federation of Industries, the Korea International Trade Association, the Korea Employers’ Federation, the Korea Federation of Small and Medium Businesses, and the Mid-Korea Federation. size, published a “joint statement by the business community urging the institutionalization of non-face-to-face treatment.” Through a statement, the 6th economic organization drew attention to the fact that faceless treatment for the whole country, which was temporarily allowed due to the corona situation for the last three years, was in danger of being stopped, and urged quickly. organizational improvement, saying he is concerned that innovative efforts are often stuck.

Currently, Korea prohibits non-face-to-face treatment in principle, and allows it only in exceptional cases. Limited to non-face-to-face treatment between ‘medical personnel and medical personnel’ in accordance with Article 34 of the Medical Service Act and temporary non-face-to-face treatment between ‘medical personnel and patients’ if national. infectious disease emergency under Article 49-3 of the Infectious Disease Prevention Act.

The business community said, “The non-face-to-face treatment between ‘medical personnel and patients’ in the mid-term period not only confirms the stability and satisfaction over the past three years, but it was also evaluated for dispelling concerns about cases not being treated. -face-to-face treatment as concentrated in large hospitals.” “February 2020 From January to now, 13.79 million people have received 36.61 million cases of non-face-to-face treatment, and no serious medical accidents have been reported.”

However, if the COVID-19 infectious disease emergency alert is downgraded from ‘severe’ to ‘warning’, non-face-to-face treatment becomes illegal without any legal basis. If the World Health Organization (WHO) raises the ‘international public health emergency’ in the near future, it is very likely that the domestic infectious disease emergency alert will be lowered accordingly.

The business world said, “Major competitors are cultivating the bio and health fields as the industries of the future and are running to take the lead, but we are hampered by regulations and do not even have a chance to ensure competitiveness.” We need to speed up institutionalisation,” he said. “It is undesirable to repeat situations where innovation is hindered by past oblivion and hindrance to the future by obsolete legal systems and vested interests,” he said.

[저작권자 @머니투데이, 무단전재 및 재배포 금지]